Open AccessEvaluating the Prognostic Role of Monocytopenia in Chemotherapy-Induced Febrile Neutropenia Patients Treated with Granulocyte Colony-Stimulating Factor
Author(s) -
Osama Alshari,
Yazan O. Al Zu’bi,
Ahmed H. Al Sharie,
Farouk H. Wafai,
Abdelwahab Aleshawi,
Farah Atawneh,
Hasan A Obeidat,
Majd N. Daoud,
MOHAMMAD KHRAIS,
Dima Albals,
Faize Tubaishat
Publication year - 2021
Publication title -
therapeutics and clinical risk management
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.719
H-Index - 55
eISSN - 1178-203X
pISSN - 1176-6336
DOI - 10.2147/tcrm.s318370
Subject(s) - medicine , neutropenia , absolute neutrophil count , granulocyte colony stimulating factor , febrile neutropenia , gastroenterology , chemotherapy , emergency department , immunology , psychiatry
Chemotherapy-induced febrile neutropenia is a common and serious oncological emergency which carries a substantial mortality and morbidity. The main objective of this study is to evaluate the usage of absolute monocyte count (AMC) at presentation as a prognostic factor for patients with chemotherapy-induced febrile neutropenia who were subsequently treated with granulocyte colony-stimulating factor (G-CSF).